Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CDx Study 906: The Clinical Utility of WATS3D (Wide Area Transepithelial Sampling With Computer-Assisted 3-Dimensional Analysis): A 5- Year Prospective Registry

NCT04312633 is registered in ClinicalTrials.gov with CDx Diagnostics as lead sponsor.

NCT NCT04312633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CDx Study 906: The Clinical Utility of WATS3D (Wide Area Transepithelial Sampling With Computer-Assisted 3-Dimensional Analysis): A 5- Year Prospective Registry
Lead sponsor
CDx Diagnostics
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2020
Completion date
November 1, 2027
Enrollment
90,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal diseases, esophageal dysplasia, gastro esophageal reflux